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Fig. 1. Simplified drawings illustrating types of portosystemic 
shunts. (A) Normal liver. (B) Intrahepatic portosytemic shunt. 
(C) Extrahepatic portosystemic shunt.
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  A 4-month-old female Holstein Friesian calf was referred to 
the  Veterinary  Teaching  Hospital,  University  of  Berne, 
Switzerland for evaluation of ataxia, weakness, apathy and 
stunted growth. Clinical examination revealed generalized 
ataxia, propioceptive deficits, decreased menace response 
and  sensibility.  Postmortem  examination  did  not  reveal 
macroscopic changes of major organs. Histologically, the 
brain and the spinal cord lesions were characterized by 
polymicrocavitation, preferentially affecting the white matter 
fibers at the junction of grey and white matter and by the 
presence  of  Alzheimer  type  II  cells.  The  liver  revealed 
lesions consistent with a congenital portosystemic shunt, 
characterized by increased numbers of arteriolar profiles 
and hypoplasia to absence of portal veins. The pathological 
investigations along with the animal history and clinical 
signs  indicated  a  hepatic  encephalomyelopathy  due  to  a 
congenital portosystemic shunt.
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  Hepatic encephalopathy (HE) refers to a spectrum of 
neuropsychiatric abnormalities associated with significant 
liver dysfunction and is commonly described in humans 
and domestic carnivores [5,6]. In veterinary medicine, 
congenital portosystemic shunts (CPSSs) (Fig. 1) are the 
most common cause of HE in young dogs and cats [7,11], 
while in large animals HE is often described with various 
hepatotoxic conditions [14]. In large domestic animals, 
CPSSs have only been sporadically reported [2,4,9,10,13]. 
Generally, the clinical signs associated with CPSS in large 
animals are unspecific and mimic those of HE; including 
progressive depression, ataxia, lethargy, apparent blindness, 
slow proprioception, hindquarters weakness and abnormal 
behavior. There are many postulated mechanisms to explain 
the pathogenesis of HE, but there is a general consensus 
that ammonia plays an important role in the dysfunction of 
astroglial cells leading to brain edema [3,5,8]. This report 
describes the clinical and neurological investigations, and 
pathological findings in a Holstein Friesian calf with 
hepatic encephalo-myelopathy due to a CPSS.
  A 2-month-old female Holstein Friesian calf was admitted 
to the Veterinary Teaching Hospital, University of Berne, 
Switzerland for evaluation of ataxia, weakness and stunted 
growth. On physical examination the animal was underweight 114    Valéria Café Marçal et al.
Fig. 2. Photomicrographs of calf cerebrum. (A) Capsule interna. 
Note diffuse severe spongy vacuolation in the adjacent areas 
between grey and white matter. H&E stain. Scale bar = 1 mm. (B)
The capsule interna showing severe white matter changes. gm; 
grey matter. wm; white matter. H&E stain. Scale bar = 100 µm.
Fig. 3. Photomicrographs of calf spinal cord. (A) Bilateral 
symmetric diffuse spongy vacuolation of the grey matter. White 
matter funiculi not affected. H&E stain. Scale bar = 500 µm. (B) 
The grey matter intermediate horn showing spongy changes 
adjacent to neuron. H&E stain. Scale  bar = 50 µm.
Fig. 4. Photomicrographs of calf liver. (A) Note a hepatic lobule 
surrounded by numerous portal spaces with absence of portal 
veins. The distance between portal spaces and central vein is 
abnormally reduced. H&E stain. Scale bar = 50 µm. (B) The 
portal area showing proliferation of arterioles and ductules with 
absence of portal vein. H&E stain.  Scale  bar = 50 µm.
with generalized muscle atrophy. Neurological examina-
tion showed generalized ataxia, propioceptive deficits, 
decreased menace response and superficial sensibility. 
Temperature, heart and breathing rates were at normal 
range. Cerebrospinal fluid analysis, blood and serum bio-
chemical analyses including liver enzymes were also within 
normal limits. Electromyographic (EMG) examination 
revealed isolated spontaneous activity such as fibrillation 
potentials in the proximal musculature of front and hind 
limbs, which indicated a nonspecific denervating neuro-
pathic or myopathic disease. The calf was treated during 
hospitalization with penicillin (40,000 IU/kg iv), dexa-
methasone (0.03 mg/kg iv; Boehringer Ingelheim, Germany) 
and thiamine (4.5 mg/kg; Vétoquinol, France) for 7 days. 
The animal recovered and was therefore taken home. Two 
months later it was returned to the Veterinary Hospital with 
a rapidly progressing debilitation. The animal was in left 
lateral recumbency, and dyspneic. Although the rectal 
temperature was normal (38.2
oC), the heart and respiratory 
rates were relatively high at 128/beats per min and 
80/breaths per min, respectively (normal ranges are 80 to 
100 beats per min and 24 to 36 breaths per min) [12]. The 
general condition of the calf deteriorated rapidly with 
progression to stupor and coma. After poor prognosis was 
established, the calf was humanely euthanized.
  Subsequently, a complete necropsy was performed, the 
analysis of which identified a poor staturoponderal de-
velopment considering the age and the breed of the animal 
(measured weight 82 kg, normal weight 136 kg). The 
general body condition was reduced with generalized muscle 
atrophy. No other macroscopical lesion was observed. 
Representative tissue samples were fixed in 10% neutral 
buffered formalin, processed by routine methods in 
ascending grades of alcohol and embedded in paraffin wax. 
Sections were cut (4 µm) and stained with hematoxylin and 
eosin. Selected brain and spinal cord tissue samples were 
additionally stained with Luxol fast blue. Immunohisto  
chemistry was performed on brain and spinal cord sections 
with a streptavidin-biotin method using an anti-bovine glial 
fibrillary acid protein (GFAP) antibody (1：1,000 DAKO, 
Denmark). Paraffin wax-embedded brain and spinal cord 
tissues of one normal age-matched calf was used as control.
  Histological examination of the CNS revealed an intense 
and widespread bilateral-symmetric spongy degeneration, 
primarily affecting the white matter with involvement of 
transitional areas between grey and white matter (Fig. 2). 
The lesion was diffusely distributed throughout the cerebrum, 
midbrain, cerebellum, brainstem and spinal cord. Spinal 
cord lesions were seen along the whole spinal cord   
involving primarily the myelinated fibers in the grey matter 
(Fig. 3). In the cerebral cortex and in the adjacent white 
matter, Alzheimer type II cells were observed as isolated 
clusters. Luxol fast blue staining of spinal cord tissue did not 
reveal any changes in myelin compound. Immunohistoche-
mically, GFAP staining did not show any obvious differences 
in staining intensity in comparison with a normal control 
calf.
  Microscopically, the hepatic portal triads presented 
numerous prominent proliferating small arterioles, 
hypoplastic to absent portal veins, proliferation of bile ducts 
and often ectasia of lymphatic vessels (Fig. 4). In 
cross-sections, skeletal muscles  revealed diffusely atrophic 
myofibers (up to 30 µm in diameter) with occasionally 
single group of angular and shrunken atrophic myofibers. 
Peripheral nerves were histologically unremarkable. 
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compatible with a hepatic encephalomyelopathy due to a 
CPSS with secondary generalized muscle atrophy. HE is 
described in association with hepatic failure and consists of 
bilateral symmetric spongy degeneration of white matter 
and the presence of single or small groups of Alzheimer 
type II cells [11]. Hepatic myelopathy is rarely described in 
veterinary medicine. A similar myelopathy as decribed in 
this case has only been described in experimentally induced 
hyperammonemic calves [1]. In human medicine, hepatic 
myelopathy is defined as a neurological complication of 
hepatic cirrhosis [5] with portal hypertension, usually 
characterized by symmetrical demyelination of the cortico-
spinal tracts [5]. In this case, the most pronounced spinal 
cord changes were restricted to the nerve fibers in the 
spinal cord grey matter without obvious demyelination 
which differs significantly to that found in human patients. 
    Hepatic atrophy and intra- or extra-hepatic vascular           
anomalies are the main gross findings reported in large 
animal species with CPSS [4,13]. Ascites, due to persistent 
portal hypertension, is commonly associated with acquired 
portosystemic shunts, and is absent in congenital 
portosystemic shunts [14]. The histological findings of the 
liver together with the absence of ascites, multiple tortuous 
shunted vessels or hepatic changes were compatible with a 
CPSS, similarly to previous reports [9]. 
  Due to the absence of clinicopathological evidence of 
hepatic dysfunction in this calf and to the unspecific 
clinical signs, a portosystemic shunt with secondary hepatic 
encephalopathy was not included in the differential diagnosis. 
However, total serum bile acid concentration, total blood 
ammonia values and sulfobromophthalein retention time 
tests, normally increased in CPSS, were not measured. The 
clinical signs observed in this reported calf (ataxia, depression, 
stupor and coma) could be explained by the hepatic 
encephalomyelopathy. However, clinical signs were far 
unspecific which led to a erroneous diagnosis. The muscle 
atrophy in this calf was most likely related to the CPSS, as 
severe liver disease are known to induce protein metabolic 
perturbations and secondary muscle atrophy [14]. Although 
EMG results suggested a peripheral nervous system 
involvement, peripheral nerves did not reveal any histopa-
thological changes. However, the presence of single group 
of atrophic myofibers in histology suggested a mild 
neurogenic atrophy, probably correlated to the severe 
spongy changes in adjacent areas of the motor neurons in 
the grey matter. The possible explanation for the initial 
recovery after antibiotic administration may be that urease- 
producing intestinal bacteria were temporarily reduced in 
the intestinal tract, hence long-term medical management 
using oral antibiotics has been described in small animals 
to inhibit both the production and absorption of potential 
gut derived CNS toxins [7].
  Congenital portosystemic shunt with secondary hepatic 
encephalomyelopathy has rarely been described in calves. 
However, hepatic encephalomyelopathy due to CPSS might 
have heterogeneous manifestations. Because of the non- 
specific associated clinical signs, it is likely that CPSS is 
often under-diagnosed. Hence, it should be considered in 
the differential diagnostic list in young animals exhibiting 
stunted growth and history of intermittent neurological 
deficits. 
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